Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Indonesia Invstble Mkt Idx MSCI Ishares | EIDO | Sep 19, 2024 | 23.32 | +2.46 |
Indust/Producer Dur Alphadex First Trust | FXR | Sep 19, 2024 | 75.69 | +2.51 |
Industrial Logistics Properties Trust | ILPT | Sep 19, 2024 | 5.13 | +1.38 |
Industrial Select Sector SPDR | XLI | Sep 19, 2024 | 134.12 | +1.72 |
Industrials ETF Vanguard | VIS | Sep 19, 2024 | 257.94 | +1.86 |
Infinera | INFN | Sep 19, 2024 | 6.69 | +0.60 |
InFinT Acquisition | IFIN | Sep 19, 2024 | 6.28 | 0.00 |
InflaRx N.V | IFRX | Sep 19, 2024 | 1.52 | +4.83 |
Inflection Point Acquisition II | IPXX | Sep 19, 2024 | 10.72 | 0.00 |
Inflection Point Acquisition II Unit | IPXXU | Sep 19, 2024 | 10.75 | 0.00 |
Infobird | IFBD | Sep 19, 2024 | 1.90 | +3.26 |
Informatica | INFA | Sep 19, 2024 | 25.51 | +1.84 |
Information Services Group | III | Sep 19, 2024 | 3.26 | -1.21 |
Information Technology ETF Vanguard | VGT | Sep 19, 2024 | 579.65 | +2.96 |
Infosys ADR | INFY | Sep 19, 2024 | 22.69 | +0.93 |
InfuSystems | INFU | Sep 19, 2024 | 6.40 | +1.59 |
ING Group ADR | ING | Sep 19, 2024 | 18.63 | +1.25 |
Ingersoll Rand | IR | Sep 19, 2024 | 97.65 | +4.17 |
Ingevity | NGVT | Sep 19, 2024 | 41.27 | +4.88 |
Ingles Markets A | IMKTA | Sep 19, 2024 | 73.50 | +0.55 |
Ingredion | INGR | Sep 19, 2024 | 136.16 | +0.34 |
Inhibikase Therapeutics | IKT | Sep 19, 2024 | 1.16 | -0.83 |
Inhibrx Biosciences | INBX | Sep 19, 2024 | 17.49 | +2.94 |
InMed | INM | Sep 19, 2024 | 0.27 | -1.87 |
InMode | INMD | Sep 19, 2024 | 17.74 | +1.60 |
INmune Bio | INMB | Sep 19, 2024 | 5.33 | +2.70 |
Innate Pharma ADR | IPHA | Sep 19, 2024 | 2.25 | 0.00 |
Inno Holdings | INHD | Sep 19, 2024 | 0.51 | -8.07 |
Innodata | INOD | Sep 19, 2024 | 14.31 | +4.15 |
Innospec | IOSP | Sep 19, 2024 | 113.96 | +1.99 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.